BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 3261968)

  • 1. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
    O'Sullivan MM; Amos N; Williams BD
    Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G; Schouten J; Cats A; Daha MR
    Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM-RF prevents complement-mediated inhibition of immune precipitation.
    Mitchell WS; Naama JK; Veitch J; Whaley K
    Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of Clq binding activity by IgM rheumatoid factor.
    Zilberfarb JL; Andrews BS; Young AC; Davis JS
    J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses.
    Sato Y; Watanabe H; Kogure A; Miyata M; Watanabe K; Nishimaki T; Kasukawa R; Fujita T
    Clin Rheumatol; 1995 Jul; 14(4):425-8. PubMed ID: 7586979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation.
    Balestrieri G; Tincani A; Migliorini P; Ferri C; Cattaneo R; Bombardieri S
    Arthritis Rheum; 1984 Oct; 27(10):1130-6. PubMed ID: 6435641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation and characterization of complement-fixing immune complexes in juvenile rheumatoid arthritis patients.
    Moore TL; Dorner RW
    Rheumatol Int; 1986; 6(2):49-52. PubMed ID: 3532285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.
    Niven IP; Whaley K
    Rheumatol Int; 1986; 6(5):205-8. PubMed ID: 3492025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 19S IgM rheumatoid factor-7S IgG rheumatoid factor immune complexes isolated in patients with rheumatoid arthritis.
    Moore TL; Dorner RW; Zuckner J
    J Lab Clin Med; 1986 May; 107(5):465-70. PubMed ID: 3701193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
    Wagner T; Abraham G; Baum J
    J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
    Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
    Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of C1q subcomponent with immunoglobulin M.
    Kimak E; Tomaszewski JJ
    Acta Biochim Pol; 1986; 33(3):179-85. PubMed ID: 2433858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
    Lorber M; Samuel D; Amlot P; Panayi GS
    Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid factor from periodontitis patients cross-reacts with epitopes on oral bacteria.
    Thé J; Ebersole JL
    Oral Dis; 1996 Dec; 2(4):253-62. PubMed ID: 9171508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4.
    Sabharwal UK; Vaughan JH; Fong S; Bennett PH; Carson DA; Curd JG
    Arthritis Rheum; 1982 Feb; 25(2):161-7. PubMed ID: 7066047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.